The role of genetic testing in epilepsy diagnosis and management

Expert Review of Molecular Diagnostics

Volumn 17, Issue 8, 2017, Pages 739-750

  Weber, Yvonne G ^a   Biskup, Saskia ^b   Helbig, Katherine L ^c   Von Spiczak, Sarah ^d,e   Lerche, Holger ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CEGAT GMBH   (Germany)

^c AMBRY GENETICS   (United States)

^d UNIVERSITY OF KIEL   (Germany)

^e Northern German Epilepsy Center for Children and Adolescents   (Germany)

Author keywords

exome; Genetic counseling; genetic epilepsies; genome; idiopathic; metabolic epilepsies; microarray analysis; next generation sequencing; personalized medicine; precision medicine

Indexed keywords

ANTICONVULSIVE AGENT;

DISEASE SEVERITY; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; GENETIC VARIATION; HEALTH CARE COST; HUMAN; INFANT DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; RECURRENCE RISK; REVIEW; SOCIAL PSYCHOLOGY; SYNAPTIC TRANSMISSION; ECONOMICS; GENETICS; LEGISLATION AND JURISPRUDENCE; PROCEDURES;

EPILEPSY; GENETIC TESTING; HUMANS;

EID: 85022097373     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1080/14737159.2017.1335598     Document Type: Review

References (103)

1. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–685.• With this manuscript, the authors published genetic novelties in epilepsies, summarized important functional findings, or defined novel classifications for genetic epilepsies.
2. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies:position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:512–521.• With this manuscript the authors published genetic novelties in epilepsies, summarized important functional findings, or defined novel classifications for genetic epilepsies.
3. Jallon P, Loiseau P, Loiseau J., Newly diagnosed unprovoked epileptic seizures:presentation at diagnosis in CAROLE study. Coordination Active du Réseau Observatoire Longitudinal de l’ Epilepsie.Epilepsia. 2001;42:464–475.
4. Engel J, Jr, International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796–803.
5. Helbig I, Lowenstein DH., Genetics of the epilepsies:where are we and where are we going? Curr Opin Neurol. 2013;26:179–185.
6. Nabbout R, Scheffer IE. Genetics of idiopathic epilepsies. Handb Clin Neurol. 2013;111:567–578.
7. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 1995;11:201–203.•• The reference is a clinical or genetic landmark for the field of genetic epilepsies.
8. +. Nat Genet. 2000;24:343–345.•• The reference is a clinical or genetic landmark for the field of genetic epilepsies.
9. Biervert C, Bc S, Kubisch C, et al. A potassium channel mutation in neonatal human epilepsy. Science. 1998;279:403–406.
10. Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 1998;18:25–29.
11. Charlier C, Singh NA, Ryan SG, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet. 1998;18:53–55.
12. Schubert S, Paravidino R, Becker F, et al. PRRT2 mutations are the major cause of benign familial infantile seizures (BFIS). Hum Mutat. 2012;33:1439–1443.
13. Schubert S, Siekierska A, Langlois M, et al. Mutations in STX1B encoding a presynaptic protein cause fever-associated epilepsy syndromes. Nat Genet. 2014;46:1327–1332.
14. Hamdan FF, Piton A, Gauthier J, et al. De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Ann Neurol. 2009;65:748–753.
15. Suls A, Mullen SA, Weber YG, et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol. 2009;66:415–419.
16. Mills PB, Surtees RA, Champion MP, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5-prime-phosphate oxidase. Hum Molec Genet. 2005;14:1077–1086.
17. Baulac S, Huberfeld G, Gourfinkel-An I, et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy:a mutation in the gamma-2-subunit gene. Nature Genet. 2001;28:46–48.
18. Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;459:1067–1072.
19. Weaving LS, Christodoulou J, Williamson SL, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75:1079–1093.
20. Tao J, Van Esch H, Hagedorn-Greiwe M, et al. Author informationMutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet. 2004;75:1149–1154.
21. Suls A, Jaehn JA, Kecskés A, et al. EuroEPINOMICS RES Consortium. De novo loss-of-function mutations in CHD2 cause a fever-Sensitive myoclonic epileptic encephalopathy sharing features with Dravet Syndrome. Am J Hum Genet. 2013;93:967–975.
22. Weber YG, Lerche H. Genetic mechanism in epilepsy. Dev Med Child Neurol. 2008;50:648–654.
23. Cossette P, Liu L, Brisebois K, et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet. 2002;31(2):184–189.
24. Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet. 2009;41(2):160–162.•• The reference is a clinical or genetic landmark for the field of genetic epilepsies.
25. De Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133:23–32.
26. Sharma S, Prasad AN. Genetic testing of epileptic encephalopathies of infancy:an approach. Can J Neurol Sci. 2013;40:10–16.
27. Helbig KL, Farwell Hagman KD, Shinde DN, et al. Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. Genet Med. 2016;18:898–905.
28. Raphael BJ. Structural variation and medical genomics. Plos Comput Biol. 2012;8:e1002821.
29. Pearson PL. Historical development of analysing large-scale changes in the human genome. Cytogenet Genome Res. 2006;115:198–204.
30. Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics. Nat Rev Genet. 2013;14:415–426.
31. Farwell KD, Shahmirzadi L, El-Khechen D, et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis:results from 500 unselected families with undiagnosed genetic conditions. Genet Med. 2015;17:578–586.
32. Wilmshurst JM, Gaillard WD, Vinayan KP, et al. Summary of recommendations for the management of infantile seizures:task force report for the ILAE commission of pediatrics. Epilepsia. 2015;56:1185–1197.
33. Devinsky O, Asato M, Camfield P, et al. Delivery of epilepsy care to adults with intellectual and developmental disabilities. Neurology. 2015;85:1512–1521.
34. Ferraro L. Pollard JR, Helbig I. Attitudes Toward Epilepsy Genetics Testing Among Adult and Pediatric Epileptologists-Results of a Q-PULSE Survey. Survey Epilepsy Curr. 2016;16:46–47.
35. Segal E, Pedro H, Valdez-Gonzalez K, et al. Diagnostic yield of epilepsy panels in children with medication-refractory epilepsy. Pediatr Neurol. 2016;64:66–71.
36. Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
37. Sobreira N, Schiettecatte F, Valle D, et al. GeneMatcher:a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–930.
38. Levenson D. Website aims to accelerate gene discovery, diagnosis, treatment:myGene2.org fosters open sharing among families, researchers, and clinicians. Am J Med Genet A. 2016;170:1388–1389.
39. Allen AS, Berkovic SF, Cossette P, et al.; Epi4K Consortium; Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217–221.• With this manuscript, the authors published genetic novelties in epilepsies, summarized important functional findings, or defined novel classifications for genetic epilepsies.
40. Halvorsen M, Petrovski S, Shellhaas R, et al. Mosaic mutations in early-onset genetic diseases. Genet Med. 2016;18:746–749.
41. Xu X, Yang X, Wu Q, et al. Amplicon resequencing identified parental mosaicism for approximately 10% of “de novo” SCN1A mutations in children with dravet syndrome. Hum Mutat. 2015;36:861–872.
42. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0):a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249–255.
43. Dorschner MO, Amendola LM, Turner EH, et al. Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am J Hum Genet. 2013;93:631–640.
44. Carmichael N, Tsipis J, Windmueller G, et al. “Is it going to hurt?”:the impact of the diagnostic odyssey on children and their families. J Genet Couns. 2015;24:325–335.
45. Rosell AM, Pena LD, Schoch K, et al. Not the end of the odyssey:parental perceptions of Whole Exome Sequencing (WES) in pediatric undiagnosed disorders. J Genet Couns. 2016;25:1019–1031.
46. Maljevic S, Krampfl K, Cobilanschi J, et al. A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy. Ann Neurol. 2006;59:983–987.
47. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus:a genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120:479–490.
48. Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet. 1198;19:366–370.
49. +2. Nat Genet. 2000;24:343–345.
50. Scheffer IE, Zhang YH, Jansen FE, et al. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev. 2009;31:394–400.
51. Striano P, Weber YG, Toliat MR, et al. GLUT1-mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology. 2012;78:557–562.
52. Borgatti R, Zucca C, Cavallini A, et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurol. 2004;63:57–65.
53. Swoboda KJ, Soong B-W, McKenna C, et al. Paroxysmal kinesigenic dyskinesia and infantile convulsions:clinical and linkage studies. Neurology. 2000;55:224–230.
54. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci. 2005;6:850–862.
55. + channels causes epilepsy. Nature. 1998;396:687–690.
56. Heron SE, Crossland KM, Andermann E, et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet. 2002;360:851–852.
57. Scalmani P, Rusconi R, Armatura E, et al. Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing benign familial neonatal-infantile seizures. J Neurosci. 2006;26:10100–10109.
58. Wolff M, Johannesen KM, Hedrich UB, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017. Epub ahead of print.
59. Becker F, Schubert J, Striano P, et al. PRRT2-related disorders:further PKD and ICCA cases and review of the literature. J Neurol. 2013;260:1234–1244.
60. Gardella E, Becker F, Møller RS, et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation. Ann Neurol. 2016;79:428–436.
61. Larsen J, Carvill GL, Gardella E, et al. Euro EPINOMICS RES Consortium CRP. The phenotypic spectrum of SCN8A encephalopathy. Neurology. 2015;84:480–489.
62. Plouin P. Benign idiopathic neonatal convulsions (familial and non-familial):open questions about these syndromes. In:Wolf P, Ed. Epileptic seizures and syndromes. London:John Libbey & Co; 1994. p. 193–201.
63. Weber YG, Berger A, Bebek N, et al. Benign familial infantile convulsions:linkage to chromosome 16p12-q12 in 14 families. Epilepsia. 2004;45:601–609.
64. Lal D, Reinthaler EM, Schubert J, et al. DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol. 2014;75:788–792.
65. Bar-Peled L, Chantranupong L, Cherniack AD, et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science. 2013;340:1100–1106.
66. Panchaud N, Péli-Gulli MP, De Virgilio C. SEACing the GAP that nEGOCiates TORC1 activation:evolutionary conservation of Rag GTPase regulation. Cell Cycle. 2013;12:2948–2952.
67. Lasarge CL, Danzer SC. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front Mol Neurosci. 2014;7:18.
68. Iffland PH, 2nd, Crino PB. Focal cortical dysplasia:gene mutations, cell signaling, and therapeutic implications. Annu Rev Pathol. 2017;12:547–571.
69. Neubauer BA, Fiedler B, Himmelein B, et al. Centrotemporal spikes in families with rolandic epilepsy:linkage to chromosome 15q14. Neurology. 1998;51:1608–1612.
70. Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45:546–551.
71. Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet. 2013;45:552–555.
72. Pippucci T, Licchetta L, Baldassari S, et al. Epilepsy with auditory features:a heterogeneous clinico-molecular disease. Neurol Genet. 2015;1:e5.
73. Møller RS, Weckhuysen S, Chipaux M, et al. Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy. Neurol Genet. 2016;2:e118.
74. Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30:335–341.
75. Fukata Y, Adesnik H, Iwanaga T, et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science. 2006;313:1792–1795.
76. Ottman R, Winawer MR, Kalachikov S, et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology. 2004;62:1120–1126.
77. Steinlein OK. Genetic mechanisms that underlie epilepsy. Nat Rev Neurosci. 2004;5:443–448.
78. Lerche H, Weber YG, Jurkat-Rott K, et al. Ion channel defects in idiopathic epilepsies. Curr Pharm. 2005;11:2737–2752.
79. Ottman R, Hirose S, Jain S, et al. Genetic testing in the epilepsies–report of the ILAE genetics commission. Epilepsia. 2010;51:655–670.•• The reference is a clinical or genetic landmark for the field of genetic epilepsies.
80. Pisano T, Numis AL, Heavin SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56:685–691.
81. Beal JC, Cherian K, Moshe SL. Early-onset epileptic encephalopathies:ohtahara syndrome and early myoclonic encephalopathy. Pediatr Neurol. 2012;47:317–323.
82. Guerrini R, Pellock JM. Age-related epileptic encephalopathies. Handb Clin Neurol. 2012;107:179–193.
83. Stromme P, Mangelsdorf ME, Shaw MA, et al. Mutations in the human ortholog of aristaless cause X-linked mental retardation and epilepsy. Nature Genet. 2002;30:441–445.
84. Evans JC, Archer HL, Colley JP, et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet. 2005;13:1113–1120.
85. Fulp CT, Cho G, Marsh ED, et al. Identification of Arx transcriptional targets in the developing basal forebrain. Hum Mol Genet. 2008;17:3740–3760.
86. Kitamura K, Yanazawa M, Sugiyama N, et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet. 2002;32:359–369.
87. Coppola G. Malignant migrating partial seizures in infancy. Handb Clin Neurol. 2013;111:605–609.
88. Barcia G, Fleming MR, Deligniere A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44:1255–1259.
89. Milligan CJ, Li M, Gazina EV, Heron SE, et al. KCNT1 of function in 2 epilepsy phenotypes is reversed by quinidine. Ann Neurol. 2014;75:581–590.
90. Mikati MA, Jiang YH, Carboni M, et al. Quinidine in the treatment of KCNT1-positive epilepsies. Ann Neurol. 2015;78:995–999.
91. Dravet C. Les epilepsies graves de l’enfant. Vie Med. 1978;8:543–548.•• The reference is a clinical or genetic landmark for the field of genetic epilepsies.
92. Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–1332.• With this manuscript, the authors published genetic novelties in epilepsies, summarized important functional findings, or defined novel classifications for genetic epilepsies.
93. Lerche H, Shah M, Beck H, et al. Ion channels in genetic and acquired forms of epilepsy. J Physiol. 2013;591:753–764.
94. Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998;39:508–512.
95. Carvill GL, McMahon JM, Schneider A, et al., EuroEPINOMICS Rare Epilepsy Syndrome Myoclonic-Astatic Epilepsy & Dravet working group. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet. 2015;96:808–815.
96. Mullen SA, Marini C, Suls A, et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol. 2011;68:1152–1155.
97. Suls A, Dedeken P, Goffin H, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter Glut1. Brain. 2008;131:1831-1844.
98. Seidner G, Alvarez MG, Yeh JI, et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet. 1998;18:188–191.
99. Weber YG, Storch A, Wuttke TV, et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Investig. 2008;118:2157–2168.
100. Mills PB, Struys E, Jakobs C, et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med. 2006;12:307–309.
101. Syrbe S, Hedrich UB, Riesch E, et al. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet. 2015;47:393–399.
102. Lemke JR, Hendrick R, Geider K, et al. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol. 2014;75:147–154.
103. Epilepsy Phenome/Genome Project Epi4K Consortium. Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy. Ann Neurol. 2015;78:323–328• With this manuscript, the authors published genetic novelties in epilepsies, summarized important functional findings, or defined novel classifications for genetic epilepsies.